Why a Calibration Workflow Matters
A trial procedure is more than a decision rule written on paper. Its operating characteristics depend on the complete chain from the scenario used to generate trial data, through the analysis applied to those data, to the final decision. Monte Carlo calibration approximates the performance of that chain by repeating it across many simulated trials. The workflow must therefore preserve the procedure being evaluated: if the data generator, analysis, or decision rule changes from one replicate to another, the simulation no longer evaluates one clearly specified procedure.
The earlier material on operating characteristics, performance metrics, scenario matrices, and trial data-generating mechanisms supplies the ingredients. Here the emphasis is on putting those ingredients into a reproducible sequence. A replicate is one simulated trial, not one patient and not one draw from a posterior distribution. Each replicate generates a complete trial dataset under a specified scenario, analyzes that dataset according to a fixed plan, and records the prespecified result.
The Workflow, from Scenario to Summary
Before starting the loop, specify the scenario and the trial procedure. The scenario states how data are generated, including the treatment effects and any relevant variation or dependence. The procedure states the design, analysis model, decision rule, and outputs to retain. These choices should be settled before inspecting simulation results. In particular, the decision rule must not be tuned after seeing which rule produces the most favorable calibration result.
For replicate \(r\), write \(D_r\) for the complete simulated trial dataset, \(A(D_r)\) for the result of the fixed analysis, and \(g(A(D_r))\) for the decision produced by the fixed rule. The full workflow is:
Record which data-generating scenario is being evaluated and the analysis and decision rule to apply. Keep these definitions unchanged across replicates in that scenario.
Simulate all trial observations according to the scenario, respecting the planned sample size, allocation, and outcome structure.
Apply the specified analysis as if \(D_r\) were the observed dataset from a real trial. Do not substitute a different model because a replicate looks unusual.
Compute the decision and save it with the scenario identifier and any other prespecified replicate-level results needed for summaries or diagnostics.
Repeat the complete-trial process, then aggregate the stored results for that scenario. Keep results from distinct scenarios separate.
The separation into stages is practical as well as conceptual. It makes errors easier to locate: an incorrect outcome distribution belongs to generation; a prior or likelihood inconsistent with the analysis plan belongs to analysis; and an incorrect threshold belongs to the decision step. Storing intermediate quantities, when feasible, can help verify what happened in a replicate without changing the procedure.
Worked Example: One Binary Trial Replicate
Worked Example: One Binary Trial Replicate
Consider a hypothetical superiority trial with 40 participants per arm and a binary response. For this scenario, responses are generated independently, with control response probability \(p_C=0.30\) and treatment response probability \(p_T=0.45\). These probabilities define the scenario; they are not estimated from the simulated dataset. The fixed analysis uses independent \(\operatorname{Beta}(1,1)\) priors for the two response probabilities and binomial likelihoods. The decision rule declares treatment favorable if the posterior mean response probability is higher in the treatment arm than in the control arm.
Suppose one generated replicate has 12 responses among 40 control participants and 18 among 40 treatment participants. Under the stated model, the posteriors are \(\operatorname{Beta}(1+12,1+40-12)=\operatorname{Beta}(13,29)\) for control and \(\operatorname{Beta}(1+18,1+40-18)=\operatorname{Beta}(19,23)\) for treatment. The posterior mean of a \(\operatorname{Beta}(a,b)\) distribution is \(a/(a+b)\), so the posterior mean difference is:
The result is positive, so this replicate meets the fixed decision rule. The workflow stores that decision, along with the scenario identifier and any prespecified quantities. This decision is not a claim that the posterior probability of treatment superiority exceeds a particular threshold: the example’s rule compares posterior means, and that is the rule being calibrated.
Why Repeating Complete Trials Gives a Useful Summary
For a fixed scenario and a fixed procedure, each simulated dataset produces an output. For example, let \(Y_r=1\) if replicate \(r\) meets the decision rule and \(Y_r=0\) otherwise. If replicates are generated independently under the same scenario, then each \(Y_r\) has the same probability of being 1. The average of these indicators summarizes how often the procedure makes that decision in the simulation.
The basic justification is that if \(q=P(Y_r=1)\), then the expected value of an indicator is its event probability: \(E(Y_r)=1q+0(1-q)=q\). By linearity of expectation, the average across \(R\) replicates also has expected value \(q\):
This explains why the replicate—not the patient—is the unit being summarized for a trial-level decision. The derivation assumes each replicate is generated under the same scenario and applies the same procedure. Detailed uncertainty measures for such summaries are a separate part of Monte Carlo calibration.
Worked Example: A Small Set of Replicates
Use the binary-trial setup above for four hypothetical replicates. For each replicate, analyze the generated counts using the same \(\operatorname{Beta}(1,1)\) priors and the same posterior-mean decision rule. With 40 participants per arm, the posterior mean difference is \((x_T+1)/42-(x_C+1)/42\), which is positive exactly when \(x_T>x_C\).
| Replicate | Control responses \(x_C\) | Treatment responses \(x_T\) | Posterior mean difference | Decision |
|---|---|---|---|---|
| 1 | 12 | 18 | \((19-13)/42=0.1429\) | Favorable |
| 2 | 15 | 13 | \((14-16)/42=-0.04762\) | Not favorable |
| 3 | 11 | 11 | \((12-12)/42=0\) | Not favorable |
| 4 | 10 | 14 | \((15-11)/42=0.09524\) | Favorable |
Two of the four replicates meet the decision rule. The fraction meeting it in this small illustrative set is \(2/4=0.50\). This is a summary of these four generated trials, not a precise characterization of procedure performance. The key workflow checks are visible: every replicate has 40 participants per arm, all use the same model and rule, and each decision is computed from its own replicate’s data.
Keeping Replicate Records and Scenario Summaries Straight
A useful record links every output to its replicate and scenario. A simple record might include a scenario label, a replicate number, the generated response counts, analysis results used by the decision rule, the final decision, and any prespecified diagnostic flag. The precise set of outputs depends on the calibration question; what matters here is that the recorded results can be traced to a particular generated trial and procedure.
When evaluating several scenarios, run or label each scenario distinctly. For example, a scenario with \(p_C=0.30\) and \(p_T=0.45\) must not be combined with one using \(p_C=0.30\) and \(p_T=0.30\) before summarization. A combined figure would mix different data-generating conditions and would not describe either scenario’s performance. A scenario matrix is useful because it gives the simulation a clear structure: each row identifies conditions under which the same procedure is evaluated.
Worked Example: Summarizing One Larger Simulation Batch
Suppose the binary-trial procedure is run for 1,000 replicates under the scenario \(p_C=0.30,\ p_T=0.45\). The stored decision indicators contain 734 ones and 266 zeros. The average indicator is:
Thus, 73.4% of the simulated trials in this batch met the decision rule. The denominator is 1,000 complete simulated trials, not 80,000 individual participants. This statement describes the observed simulation summary under this scenario; it does not by itself report the uncertainty of the Monte Carlo estimate or establish performance under other scenarios.
Diagnostics, Alternatives, and Limitations
A sound workflow includes checks at the points where errors can enter. Confirm that generated dataset sizes and allocation match the design; verify that outcomes have the values and structure allowed by the scenario; and check that the analysis is applied to the intended data fields. Confirm that the same prior, likelihood, and decision threshold are used on every replicate. Finally, verify that every stored decision corresponds to a completed replicate and that its scenario label is correct. If some replicate fails to analyze, record and investigate the failure rather than silently dropping it: failures may be related to the data and can distort a summary.
Monte Carlo simulation is not the only way to evaluate a procedure. If an operating characteristic can be obtained exactly or accurately by enumerating all possible datasets, enumeration can avoid simulation variability. For small discrete trials, that may be feasible; for complex designs or large data spaces, the number of possible datasets can make it impractical. Simulation is flexible, but it approximates performance using a finite collection of generated trials. It also cannot repair a misspecified scenario or an implementation that does not match the intended analysis.
Another distinction matters when Bayesian computation is itself simulation-based. Posterior draws used within a replicate are inner computation for that trial’s analysis; independently generated complete trials are outer Monte Carlo replicates for calibration. Confusing these levels can lead to counting posterior draws as if they were separate trials. If the analysis uses posterior simulation, its within-replicate computation must be sufficiently accurate to implement the fixed decision rule reliably, but increasing posterior draws does not increase the number of simulated trials.
Common Workflow Mistakes
- Changing the rule after seeing results. Choosing a threshold that makes the simulated performance look desirable means the simulation no longer evaluates the prespecified procedure.
- Mixing scenarios. Pooling trial results generated under different assumptions produces a summary with no clear scenario-specific interpretation.
- Counting observations as replicates. The trial-level decision is generated once per complete simulated trial; patients within a trial are not independent evaluations of that decision rule.
- Ignoring failed analyses. Silently excluding failed replicates can change the set being summarized. Diagnose failures and report how they are handled.
- Treating posterior draws as trial replicates. Posterior draws support an analysis within a simulated trial; they do not replace repeated generation of complete trials.
A practical standard is to be able to explain, for any stored row, which scenario generated the data, how those data were analyzed, which rule produced the decision, and which result was recorded. If that chain cannot be reconstructed, the calibration result is difficult to verify.
Check Your Understanding
Answer each question using the workflow and definitions above. A brief solution follows each item.
- A simulation generates 500 complete trials and 20,000 posterior draws within each trial. How many trial replicates are there?
Solution: There are 500 trial replicates. The posterior draws are inner computations within those trials, not additional trials. - In one binary-trial replicate, \(x_C=14\) and \(x_T=16\), with 40 participants per arm and the \(\operatorname{Beta}(1,1)\) priors and decision rule used above. What is the posterior mean difference, and what is the decision?
Solution: The difference is \((17-15)/42=2/42\approx0.04762\). It is positive, so the replicate meets the rule. - Why should trials generated under two different scenarios be summarized separately?
Solution: Each scenario defines different conditions for the procedure’s performance. Pooling outputs would mix those conditions and would not give a scenario-specific summary. - A researcher changes the decision threshold halfway through a run after seeing the early results. What is wrong with this workflow?
Solution: The replicates no longer evaluate one fixed procedure. The rule must be specified before the simulation and applied consistently. - A batch has 1,000 complete trials, and 621 meet the decision rule. What fraction of simulated trials meet it?
Solution: The fraction is \(621/1000=0.621\), or 62.1%. It is a summary of this batch under its scenario, not a result for individual patients.